Randy Milby - 19 May 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Issuer symbol
THAR
Transactions as of
19 May 2022
Net transactions value
+$908
Form type
4
Filing time
19 May 2022, 16:59:40 UTC
Previous filing
19 Apr 2022
Next filing
23 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HILS Common Stock Purchase $458 +500 +0.02% $0.9153 2,935,039 19 May 2022 Direct
transaction HILS Common Stock Purchase $450 +500 +0.02% $0.9000 2,935,539 19 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.